Recall: D-0434-2023

Class II - Potentially Harmful

Class IIClassification

2023-03-01Initiated

TerminatedStatus

B. Braun Medical IncFirm

Product

Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.Braun Medical Inc, Bethlehem, PA. 18018-3524 USA. NDC 0264-9587-20.

Reason

Subpotent Drug: low Anti-Factor IIa potency.

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA. If you take this product, talk to your pharmacist or doctor before stopping it.